20 June 2013
Keywords: wyeth, market, own, products, japan, following, termination
Article | 15 April 2002
Following the termination of its contracts with YamanouchiPharmaceutical of its two lead central nervous system drugs, effective March 31, Wyeth Lederle ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.